Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Benzonatate recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Benzonatate (7 total). Check the affected lots below.

Most common reason: Failed specification (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Benzonatate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Benzonatate recalls on record

none so far in 2026; 7 on record, newest first
Class III · Low risk

Benzonatate Capsules

Superpotent drug: Assay results were slightly above specification at the time zero point.

Ongoing Wrong potency / content Amerisource Health Services LLC NDC 68084-214-01 D-0257-2024
Class I · High risk

Benzonatate capsules

Labeling: Label Mix-up: Bottle labeled as Benzonatate 100 mg capsules contained Benzphetamine 50 mg tablets and a bottle labeled as Benzphetamine 50 mg tablets contained Benzonatate 100 mg capsules.

Terminated Labeling / mix-up Calvin Scott & Company, Inc. NDC 67877-0573-05 D-1124-2022
Class III · Low risk

Benzonatate capsules

Failed Stability Specifications: Out of Specification results obtained for preservative Methylparaben content.

Terminated Stability / shelf life Strides Pharma INC NDC 64380-713-06 D-0858-2017
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications; recall initiated by manufacturer due to reports of wet capsules

Terminated Failed specification American Health Packaging NDC 68084-214-01 D-0430-2015
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-247-01 D-0325-2015
Class II · Moderate risk

Benzonatate Capsules

Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Terminated Failed specification Zydus Pharmaceuticals USA Inc NDC 68382-248-01 D-0299-2015
Class III · Low risk

BENZONATATE Capsules

Presence of Foreign Capsules/Tablets: Benzonatate 100 mg co-mingled with benzonatate 200 mg capsules.

Terminated Particulate / foreign matter Zydus Pharmaceuticals USA Inc D-0289-2015